-transparent.png){kind=logo}
Of 200 patients who received porcine heterograft cardiac valves, the first 100 did not receive postoperative anticoagulant therapy. In the second 100 patients anticoagulant measures were used when thrombogenic factors not related to the prosthesis were evident. Anticoagulation should be employed following mitral valve replacement while factors contributing to thromboembolism prevail. The conditions that tend to induce vascular stasis in the left atrium followed by embolism are chronic atrial fibrillation, a large dilated left atrium and a calcified left atrial wall. The results of our study provide assurance of the continued use of the porcine bioprosthesis.
Related Publications
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
June 1975,
Nursing times,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
February 1971,
Israel journal of medical sciences,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
October 1978,
American heart journal,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
October 1980,
Circulation,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
April 1979,
British heart journal,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
April 1971,
The Journal of thoracic and cardiovascular surgery,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
February 1983,
The American journal of cardiology,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
May 1970,
Circulation,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
January 1983,
Indian heart journal,
W R Jamieson, and
A I Munro, and
R T Miyagishima, and
P Allen
February 1977,
Journal of the Iowa Medical Society,
